RxDoctor Payments Data

Wanda Stroupe, NP

Nurse Practitioner · Ripley, MSNPI 1902876238

Payments from drug & device makers

$2,843in general payments, 2019–2025

Across 94 payments — averaging $30.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$528
  • Bayer$439
  • Novo Nordisk$379
  • Teva Pharmaceuticals USA, Inc.$247
  • Boehringer Ingelheim$205
  • AbbVie$179
  • plus $866 from 12 others

What the payments were for

  • Food & beverage$2,843100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,843 in reported general payments places this provider in the 85th percentile of 1,090 nurse practitioner providers in Mississippi.

See all nurse practitioner providers in Mississippi

Medicare billing

Part B allowed, 2024
$84,842
Medicare patients
129
Services billed
2,801

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban29$27,352
JanuviaSitagliptin Phosphate18$14,241
FarxigaDapagliflozin Propanediol11$9,686
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$6,085
Famotidine88$1,152
Omeprazole65$952
Atorvastatin Calcium98$755
Pantoprazole Sodium91$701
Montelukast Sodium56$629
Fluticasone Propionate45$531
Albuterol Sulfate HfaAlbuterol Sulfate17$482
Ezetimibe32$472
Simvastatin60$463
Losartan Potassium53$454
Lisinopril80$453

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$15$27,35229 claims
AstraZenecaFarxiga, Breztri Aerosphere$528$15,77122 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,090 nurse practitioner providers in Mississippi.

Other nurse practitioner in Ripley

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →